According to these articles, 1 & 2, the FDA has granted Gilead the go ahead with a new once daily regimen. It will be called, Biktarvy. Sounds like a German version of the 1960's show, Daktari. It is very similar to the Descovy, which is basically an altered form of Truvada. It has Bictegravir as an added component. I couldn't find much on Bictegravir besides this pdf.
The 1st article is very light, but holds a very important detail about this new med, the cost, which will be over $35,000 annually. It's expected to quickly become the gold standard for HIV treatment. Of course, it's a literal gold mine for Gilead. The 2nd article goes much further details of the matter.
Give them a read. This is medication has been approved & will be hitting the market soon.
Cya...
No comments:
Post a Comment